Amortization expense was $1.3 million and $0.4 million for the three months ended March 31, 2019 and 2018 respectively.
For the three months ended March 31, 2019 and 2018, we incurred acquisition and integration related expenses and amortization of acquired intangibles of $1.3 million and $0.2 million respectively, related to these acquisitions.
Our effective tax rate increased from an expense of 15.1%, excluding the tax effect of the bargain purchase gain, in the three months ended March 31, 2018, to an expense of 28.6% in the three months ended March 31, 2019.
The majority of the revenue from this segment is from hardware sales.
Our products continue to become more complex in both size and functionality as many of our product offerings migrate from line card applications to total systems.
The increase in the effective tax rate between the two periods is primarily driven by the shift to profitability in the current quarter.
Network Solutions includes hardware products and software-defined next-generation virtualized solutions used in service provider or business networks, as well as prior generation products.
Contingent liabilities with a fair value totaling $1.2 million were recognized at the acquisition date, the payments of which are dependent upon SmartRG achieving future revenue, EBIT or customer purchase order milestones during the first half of 2019.
There were no stock options granted during the three months ended March 31, 2019 or 2018.
No change in fair value was recognized during the three months ended March 31, 2019.
The following table presents information about the reported sales and gross profit of our reportable segments for the three months ended March 31, 2019 and 2018.Other income (expense), net increased from $0.1 million of expense in the three months ended March 31, 2018 to $0.9 million of income in the three months ended March 31, 2019.
Network Solutions cost of sales, as a percent of that segmentâ€™s sales, decreased from 65.2% in the three months ended March 31, 2018 to 56.2% in the three months ended March 31, 2019.
Research and development expenses decreased 3.7% from $32.8 million in the three months ended March 31, 2018 to $31.6 million in the three months ended March 31, 2019.
As a percentage of sales, research and development expenses decreased from 27.2% in the three months ended March 31, 2018 to 22.0% in the three months ended March 31, 2019.
As a percentage of sales, cost of sales decreased from 67.1% in the three months ended March 31, 2018 to 57.8% in the three months ended March 31, 2019.The fluctuation compared to prior periods is due to an increase in U.S. dollar-denominated billings in a non-U.S. dollar denominated subsidiary as well as an increase in international sales.